Full-Time
Machine Learning Associate Advisor
Multiple Teams
Posted on 9/23/2025
Cigna Group
1,001-5,000 employees
Philanthropic foundation funding health-focused nonprofits
No salary listed
Hyderabad, Telangana, India
Hybrid
Hybrid working model (3 days WFO and 2 days WAH)
 AI & Machine Learning (3) |
|---|
| , , |
- Foundations in Machine Learning and Deep Learning: Strong understanding of algorithms, neural networks, supervised and unsupervised learning, and experience with frameworks such as TensorFlow, PyTorch, and Keras.
- Generative AI: Practical knowledge of generative AI techniques and architectures, including GANs (Generative Adversarial Networks), VAEs (Variational Autoencoders), and Transformers for tasks such as content generation, summarization, and synthetic data creation.
- Natural Language Processing (NLP): Proficiency in NLP techniques and libraries such as spaCy, NLTK, and Hugging Face Transformers for tasks like text generation, classification, and conversational AI.
- Prompt Engineering & Fine-Tuning: Basic understanding of prompt engineering, fine-tuning of large language models, and Retrieval-Augmented Generation (RAG) for domain-specific applications.
- Model Deployment: Experience deploying models using TensorFlow Serving, TorchServe, or cloud-based platforms like AWS SageMaker and Google AI Platform.
- Programming Expertise: Strong foundation in Python and practical experience applying it in AI/ML workflows to transition from traditional development to agile, innovation-driven solutions.
- Containerization & Orchestration: Hands-on experience with Docker and Kubernetes/OpenShift for packaging and managing scalable applications.
- CI/CD Pipelines: Knowledge of continuous integration and deployment practices, tools, and automation strategies.
- Security Best Practices: Understanding of security principles including Identity and Access Management (IAM), encryption, and network security to ensure safe deployment of AI/ML solutions.
- Cloud Services: Familiarity with cloud platforms such as AWS, Google Cloud, and Azure for deploying, managing, and scaling applications and machine learning models.
- Lead the design and implementation of intelligent automation solutions that streamline the Software Development Lifecycle (SDLC), from development through testing and deployment.
- Provide comprehensive consultation to business units, IT management, and technical teams on all aspects of application development, testing, and automation across diverse environments.
- Develop self-service onboarding kits and reusable frameworks that enable rapid adoption by users with varying technical backgrounds, requiring no additional coding or maintenance.
- Offer architectural leadership and AI/ML guidance, ensuring alignment with enterprise technology strategy and long-term scalability.
- Conduct in-depth research to identify and recommend efficient, cost-effective, and scalable AI/ML automation solutions across the SDLC—including test data generation, code/test case/script generation, root cause analysis, and predictive analytics.
- Collaborate with cross-functional stakeholders—developers, testers, business analysts, and operations teams—to ensure solutions are adaptable, reusable, and reduce duplication across the enterprise.
- Enhance quality assurance through intelligent validation, monitoring, and automation strategies that support both functional and non-functional testing.
- Increase developer productivity by automating repetitive tasks and integrating intelligent tooling into development workflows.
- Accelerate speed to market by enabling faster, more reliable delivery of features through CI/CD and DevOps practices.
- Demonstrate industry-leading technical expertise to improve product quality and optimize day-to-day engineering operations.
- Understand and manage upstream/downstream impacts across front-end and back-end architectural modules.
- Use heat matrices and analytics to prioritize quality and development engineering resources on high-impact areas while identifying lower-priority zones.
- Proactively monitor and manage automation solutions to ensure scalability, stability, flexibility, simplicity, performance, availability, security, and capacity.
- Troubleshoot and optimize automation artifacts for seamless execution in CI/CD pipelines and local environments, minimizing dependency conflicts and reducing cycle time.
- Drive adoption of automation solutions across teams, ensuring they are low-maintenance, enhancement-ready, and require no deep technical intervention.
- Promote a culture of automation, encouraging teams to adopt automated processes wherever feasible.
- Serve as a recognized subject matter expert (SME) in AI/ML-driven automation and enterprise engineering practices.
- Proven experience leading or contributing to enterprise-scale AI/ML automation initiatives across the full Software Development Lifecycle (SDLC).
- Demonstrated success in designing and deploying self-service, low-maintenance automation solutions adopted by cross-functional teams including development, QA, business, and operations.
- Experience working in Agile environments with a strong understanding of DevOps principles and CI/CD integration.
- Hands-on experience with implementing Generative AI solutions in real-world applications, including content generation, summarization, or intelligent test automation.
- Track record of reducing product duplication and improving system quality through reusable architecture and shared tooling.
- Experience collaborating with architecture, security, and infrastructure teams to ensure scalable, secure, and compliant solution delivery.
- Familiarity with enterprise environments involving hybrid cloud infrastructure, container orchestration, and secure data pipelines.
- Strong communication and leadership skills, with the ability to influence stakeholders and drive adoption of innovative technologies across diverse teams.
The Cigna Group Foundation is the philanthropic arm of The Cigna Group, a global health company. It provides grant funding to non-profit organizations with a focus on health and well-being, particularly youth mental health, veteran mental health, and community well-being. The foundation announces grant programs, invites non-profits to apply, and selects recipients through structured funding cycles, often supporting multi-year, multi-million dollar initiatives and forming partnerships with grantees. Its goal is to improve the health and well-being of individuals, families, and communities by funding targeted social impact programs through corporate philanthropy.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
Simplify's Take
What believers are saying
- Evernorth Signature rebate-free PBM reduces brand-name drug costs by 30% by 2028.
- Prior authorization reforms cut medical authorization volume by 70% through end-2026.
- AI-driven efficiency reduced inbound call volumes 20-25% over two years, boosting member satisfaction.
What critics are saying
- ACA exit by 2027 signals portfolio contraction amid rising medical utilization pressures.
- EviCore sale exploration exposes Cigna to reputational damage from care denial scandals.
- CEO transition and aggressive pruning distract management from specialty pharmacy growth competition.
What makes Cigna Group unique
- Foundation commits $9M over three years to youth mental health across ten priority states.
- Trauma-informed grant model reaches 34,000+ youth, families, and professionals in underserved communities.
- Structured $150K grant cycles prioritize social-emotional learning and family-school partnerships nationwide.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Holidays
Wellness Program
Company News
The Cigna Group names Brian Evanko CEO. March 3, 2026 Brian Evanko The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO. Throughout his tenure - including roles as president and chief executive officer of Cigna Healthcare and chief financial officer of The Cigna Group - Evanko has demonstrated visionary leadership and delivered consistently strong performance, while guiding the organization through periods of significant change. He currently oversees the company's business portfolio across Cigna Healthcare and Evernorth Health Services, driving transformative innovation and accelerating the use of data, technology, and AI to make health care simpler, more personalized, and more affordable. "Brian is an exceptional leader and the right person to guide The Cigna Group into its next chapter," said Cordani. "The status quo in health care today is unsustainable. By leading from the front and making meaningful changes, we have delivered sustained impact for customers and strengthened the company strategically, operationally, and financially. Now is the right time to transition leadership to build on our progress and carry our momentum forward." "David and Brian have worked together for many years, and under their leadership, The Cigna Group is defining a new era in health care, centered on delivering more personalized and affordable care," said Eric Wiseman, lead independent director of the Board of Directors. "Brian's purpose-driven, performance-focused leadership, experience across every dimension of our business, and future-focused approach uniquely position him to be the company's next CEO." "As I assume this role, I am grateful to David for his mentorship and to our Board of Directors for their trust," Evanko said. "Over my nearly 30 years with the company, I have seen firsthand the strength of our businesses, the talent of our team, and our deep commitment to serving customers and clients. I am excited to build on our strong foundation as we work to further modernize health care, expand our reach, and fuel growth." Wiseman continued, "On behalf of the Board, I want to express our gratitude for David's vision and leadership over nearly 17 years as CEO. During his tenure, David championed programs that improved affordability for customers and clients with differentiated services and capabilities. He strategically expanded and shaped the portfolio - from a traditional insurer, serving 46 million customers and generating $18 billion of annual revenue to a global health company, serving 180 million customer relationships and growing annual revenue to $275 billion. As a result of this transformation, the company's total shareholder return increased by more than 750%. We are pleased that The Cigna Group will continue to benefit from David's insights and experience as Executive Chair." Cordani and Evanko will work closely during the transition period through July 1, 2026, when Evanko will assume the role of CEO and Cordani will become Executive Chair of the Board. Cordani concluded, "Leading The Cigna Group has been the privilege of a lifetime. I am especially proud of how our team has worked to build a stronger future - not just for today, but for the next generation. By focusing on the customer, delivering value, and driving positive change, we are making a difference, one person at a time." Reaffirmed Financial Outlook The Company is reaffirming projected full year 2026 consolidated adjusted income from operations of at least $30.25 per share. The Company is also reaffirming 2026 Evernorth pre-tax adjusted income from operations of at least $6.9 billion, and Cigna Healthcare pre-tax adjusted income from operations of at least $4.5 billion.
The Cigna Group announced that president and chief operating officer Brian Evanko will succeed David Cordani as chief executive officer on 1 July 2026. Cordani, who has led the company for nearly 17 years, will retire as CEO and become executive chair of the board. During Cordani's tenure, The Cigna Group transformed from a traditional insurer serving 46 million customers with $18 billion in annual revenue to a global health company serving 180 million customer relationships with $275 billion in revenue. Total shareholder return increased by more than 750%. Evanko, who has nearly 30 years with the company, currently oversees Cigna Healthcare and Evernorth Health Services. The company reaffirmed its 2026 financial outlook of at least $30.25 per share in consolidated adjusted income from operations.
UMSL Addiction Science Team receives $250,000 grant from The Cigna Group Foundation to advance health equity. The funding supports the creation of the St. Louis Medication Access Project, which will provide medication lockboxes and transportation assistance to individuals seeking treatment. This funding will support the creation of the St. Louis MAP - Medication Access Project - that aims to reduce barriers to methadone treatment for opioid use disorder by providing individuals seeking treatment with medication lockboxes and transportation assistance, including bus passes and rideshare vouchers. The project is focused primarily on communities in St. Louis where overdose rates are highest, and it aligns with The Cigna Group Foundation's goal of strengthening community-based programs designed to reduce long-standing health disparities and expand access to essential resources for underserved populations. "We are really grateful to The Cigna Group Foundation for this funding," said Rachel Winograd, who leads the UMSL Addiction Science Team and serves as an associate professor and principal investigator within psychological sciences and the Missouri Institute of Mental Health. "This allows us to build on some informal activities and community partnerships that we've had in recent years to make something more rigorous and robust that we can actually plan out intentionally and draw solid learnings from." Winograd has been directing statewide efforts to combat the overdose crisis for nearly a decade. She and her colleagues on the Addiction Science Team are committed to expanding access to medical treatment and harm reduction strategies to assist people battling opioid and other drug use disorders. The team has helped increase the availability of naloxone across the state to respond to instances of overdose and have also been able to identify gaps that make it challenging for individuals to access the treatment they need, including transportation and requirements by clinics that patients have lockboxes for medication. "There are so many barriers associated with methadone treatment, but there are some that feel very tangible and addressable," Winograd said. "Our work is about reducing as many barriers as we can at as many levels as we can, whether that's structural with the state or federal policy, whether that's provider level with individual clinics or the people who work within them, or at the patient level, about their own awareness, knowledge, attitudes or access. We are trying to chip away one level and one barrier at a time." Research shows that up to 80% of a person's health outcomes are influenced by social drivers of health, including housing stability, education, economic opportunity, transportation and food access. These factors disproportionately affect underserved communities, contributing to preventable gaps in health status, life expectancy and chronic disease outcomes. "Health equity can only be achieved when we address the root causes of disparities and work alongside trusted local organizations," said Celeste Player, Pharm D, board member for The Cigna Group Foundation. "We are honored to support the University of Missouri-St. Louis Addiction Science Team as they work to remove systemic barriers and expand access to vital health resources. Together, we're helping create more equitable outcomes for all." The Cigna Group Health Equity Impact Fund focuses on U.S. cities with pronounced health inequities, including St. Louis. Research shows that residents of St. Louis have disproportionately higher rates of death from substance use disorders and are more likely to visit the emergency room for a mental health challenge than other counties in Missouri. The Cigna Group Foundation has a long history of impactful partnerships with nonprofits, and announced a philanthropic and community engagement initiative that has committed more than $27 million in grants over three years to nonprofit organizations focused on improving youth and veteran mental health and reducing barriers to health equity. The Health Equity Impact Fund is part of these grants. Feb 27, 2026 Feb 23, 2026
The Cigna Group reported 2025 total revenues of $274.9 billion, up 11% year-over-year, with shareholders' net income of $6.0 billion, or $22.18 per share. Adjusted income from operations reached $8.0 billion, or $29.84 per share, increasing 4% from 2024. Fourth-quarter 2025 adjusted income from operations rose 16% to $2.1 billion, or $8.08 per share, driven by strong performance in Cigna Healthcare and Evernorth Health Services. Growth was fuelled by specialty pharmacy expansion and existing client relationships. The company projects 2026 adjusted income from operations of at least $7.950 billion, or at least $30.25 per share, with revenues of approximately $280 billion. Total customer relationships reached 188.4 million, up 3% from 2024. The board increased the quarterly dividend to $1.56 per share, up from $1.51.
CHDI receives $150,000 grant from The Cigna Group Foundation to expand access to school-based peer support program. Media release. CONNECTICUT - CHDI has been awarded a grant of $150,000 from The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE: CI), to help address the youth mental health crisis by expanding access to an innovative school-based peer support program in Connecticut. Students Supporting Students (SSS) is a school-based peer support model designed to empower middle and high school youth to recognize mental health symptoms, reduce stigma, and promote help-seeking behaviors. Activities will include staff and student training and ongoing technical assistance to empower student peer support teams to develop and lead events, educational materials, and awareness campaigns at their schools. "With this generous grant from The Cigna Group Foundation, we will be able to empower youth across Connecticut to play a lead role in improving mental health knowledge, reducing stigma, and increasing mental health support in schools," said Jeff Vanderploeg, PhD, President and CEO of CHDI. "We are grateful for The Cigna Group Foundation's support in this mission." "In Connecticut, with over half of school-aged youth classified as 'high need' and many schools operating below recommended staffing levels for mental health support staff, this program addresses an urgent need," added Jamie LoCurto, PhD, a senior associate at CHDI and the project's director. "Local nonprofits continue to be a tremendous source of support for kids and teens grappling with mental health issues, and we are thrilled to team up with CHDI to advance their student peer support program that will help with post-pandemic stress among youth," said Melissa Skottegaard, board chair, The Cigna Group Foundation. "The youth mental health crisis continues to weigh heavily on our communities, and it is our privilege to partner with trusted nonprofits to continue this important work." According to an analysis by The Cigna Group's Evernorth Research Institute, the number of young people with mental health conditions has increased 28% since 2018, and the number of young people with at least two mental health diagnoses has risen 48% over the same period. Inadequate levels of social and emotional functioning are increasingly recognized as central to many public health problems, and more than two out of three children and adolescents experience trauma by age 16. The Cigna Group Foundation has a long history of impactful partnerships with nonprofits, and in 2024 announced a philanthropic and community engagement initiative committing more than $27 million in grants over three years to nonprofit organizations focused on improving youth mental health, improving veteran mental health, and reducing barriers to health equity. About the Child Health and Development Institute (CHDI). The Child Health and Development Institute is a nonprofit organization providing a bridge to better and more equitable behavioral health and well-being for children, youth, and families. Child Health and Development Institute of Connecticut collaborate with policymakers, providers, and partners to transform child-serving systems, disseminate evidence-based and best practices, and advance policy solutions that result in better outcomes for children in Connecticut and beyond. Learn more at www.chdi.org. About The Cigna Group. The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. Child Health and Development Institute of Connecticut relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions and has more than 180 million customer relationships around the world. Learn more at thecignagroup.com. About The Cigna Group Foundation. The Cigna Group Foundation is a private foundation funded by contributions from The Cigna Group (NYSE:CI) and its subsidiaries. The Cigna Group Foundation aims to support, collaborate, and convene with nonprofit organizations addressing society's greatest health challenges. In addition to increasing access to programs and care in geographies demonstrating significant need, the Foundation responds with humanitarian aid relief during critical times and strengthens colleagues' support of causes through matching donations and volunteer rewards. To learn more, visit www.thecignagroup.com/community. Advancing school mental health. CHDI partners with schools and districts to support student mental health and well-being by building schools' capacity to prevent, identify, and address behavioral health concerns. Partner with Child Health and Development Institute of Connecticut to strengthen student mental health. To learn more about the Students Supporting Students program, contact Jamie LoCurto: